Figure 2.

The process for MM response prediction of bortezomib, cyclophosphamide, and dexamethasone (BCD) and bortezomib, lenalidomide, and dexamethasone (VRD).

The process for MM response prediction of bortezomib, cyclophosphamide, and dexamethasone (BCD) and bortezomib, lenalidomide, and dexamethasone (VRD).